Clinical Trial Update: Cethrin in Acute Cervical Spinal Cord Injury [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 trial of Cethrin for acute cervical spinal cord injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Cethrin

Snippet

Sponsor: BioAxone BioSciences, Inc. | Conditions: Spinal Cord Injury | Phase 2, Phase 3 | Status: WITHDRAWN